Old Web
English
Sign In
Acemap
>
Paper
>
81: Efficacy and safety of AP26113 in ALK+ non-small cell lung cancer (NSCLC), including patients with brain metastases
81: Efficacy and safety of AP26113 in ALK+ non-small cell lung cancer (NSCLC), including patients with brain metastases
2015
Scott N. Gettinger
Lyudmila Bazhenova
Ravi Salgia
Corey J. Langer
Kathryn A. Gold
Rafael Rosell
Alice T. Shaw
Glen J. Weiss
Narayana I. Narasimhan
David J. Dorer
Victor M. Rivera
T Clackson
Frank G. Haluska
D.R. Camidge
Keywords:
non-small cell lung cancer (NSCLC)
Pathology
Medicine
Internal medicine
Oncology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]